About Johnson & Johnson Innovative Medicine
J&J Innovative Medicine, the US-based pharmaceutical company, has a global supply network with production sites in Europe, Asia-Pacific, South America, and North America.
The challenge
The company had an organizational change from decentral supply planning to a global E2E planning optimization. Situations of supply shortages require efficient allocation management. The company lacked standardized processes and formalized decision-making required for allocation planning.
The project
EyeOn was requested to support J&J IM in a 2-phase allocation planning set-up. First, setting up a standardized allocation planning process was addressed with one global approach for tooling used. After that, the team started to run the global monthly allocation planning cycle for an international brand and coordinate supply flows in the global supply network (15+ plants) for a period of 1 year.
Results
The outcome of the joint effort was a standardized allocation planning process and alignment set-up and a smooth handover of allocation planning activities to the operational team.
Ready to optimize your allocation management?
Get in touch with us to learn how EyeOn can help you set up a standardized allocation planning process and reduce supply shortages.